Clinical Trials Browser

Terminated × Glioblastoma × Everolimus × Clear all

NCT01508104 2017-08-23

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

Phase 1 Terminated

CNSEndocrineNET

Brain Neoplasms, Glioblastoma, Neoplasms, Neuroendocrine Tumors

NCT00515086 2011-09-22

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Terminated

41 enrolled 11 charts

Dyschromatosis symmetrica hereditaria 1, Glioblastoma